Aura Biosciences, Inc. (AURA)
NASDAQ: AURA · IEX Real-Time Price · USD
7.83
+0.13 (1.69%)
Mar 28, 2024, 2:53 PM EDT - Market open

Aura Biosciences Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Year 20232022202120202019
Net Income
-76.41-58.76-46.19-30.13-30.23
Depreciation & Amortization
3.132.150.830.830.51
Share-Based Compensation
8.776.412.310.740.51
Other Operating Activities
0.66-4.410.65-3.682.52
Operating Cash Flow
-63.85-54.6-32.41-24.32-20.67
Capital Expenditures
-0.71-1.09-2.13-0.77-2.22
Change in Investments
-113.25-66.78000
Investing Cash Flow
-113.96-67.87-2.13-0.77-2.22
Share Issuance / Repurchase
97.2995.6379.050.160.06
Debt Issued / Paid
0000-0.04
Other Financing Activities
--87.219.8739.71
Financing Cash Flow
97.2995.63166.2610.0439.73
Net Cash Flow
-80.52-26.84131.72-15.0616.84
Free Cash Flow
-64.56-55.7-34.54-25.09-22.89
Free Cash Flow Per Share
-1.63-1.86-6.69-68.33-4.94
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).